Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer. [electronic resource]
Producer: 19980713Description: 2267-73 p. digitalISSN:- 0007-0920
- Antibiotics, Antineoplastic -- therapeutic use
- Antigens, Neoplasm
- Biomarkers, Tumor -- analysis
- Breast Neoplasms -- chemistry
- DNA Topoisomerases, Type II -- analysis
- DNA, Neoplasm -- genetics
- DNA-Binding Proteins
- Enzyme Inhibitors -- therapeutic use
- Epirubicin -- therapeutic use
- Female
- Humans
- Immunohistochemistry
- Isoenzymes -- analysis
- Middle Aged
- Ploidies
- Predictive Value of Tests
- Prognosis
- Receptor, ErbB-2 -- analysis
- Receptors, Estrogen -- analysis
- Receptors, Progesterone -- analysis
- S Phase -- physiology
- Topoisomerase II Inhibitors
- Tumor Suppressor Protein p53 -- analysis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.